The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADIENT PLC | ORD SHS | G0084W101 | 7,559 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| ALPHABET INC | CAP STK CL C | 02079K107 | 959 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| ENERGY RECOVERY INC | COM | 29270J100 | 1,411 | 178,592 | SH | SOLE | 178,592 | 0 | 0 | ||
| HILL INTERNATIONAL INC | COM | 431466101 | 4,418 | 930,000 | SH | SOLE | 930,000 | 0 | 0 | ||
| HUDSON TECHNOLOGIES INC | COM | 444144109 | 3,643 | 466,501 | SH | SOLE | 466,501 | 0 | 0 | ||
| PEREGRINE PHARMACEUTICALS IN | COM PAR | 713661502 | 9,015 | 2,871,000 | SH | SOLE | 2,871,000 | 0 | 0 | ||
| RECRO PHARMA INC | COM | 75629F109 | 2,109 | 234,902 | SH | SOLE | 234,902 | 0 | 0 | ||
| VOYA FINL INC | COM | 929089100 | 6,582 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||